r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

RB

Robert Barrow

Insider · Chief Executive Officer · DFTX

Robert Barrow files insider transactions with the SEC as a chief executive officer of Definium Therapeutics (DFTX). We hold 3 disclosed purchases and sales filed since 19 January 2022, 2 of them in the last 90 days.

  • Files forDFTX
  • Disclosed buys and sells3 in all, 2 in the last 90 days
  • Last disclosure4 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 3 February 2026 — 3 September 2026Chief Executive Officer · Definium Therapeutics (DFTX)9 Form 4 lines · source: SEC Form 4
  • Filed 15 January 2022 — 26 December 2025Chief Executive Officer · Mind Medicine (MindMed) (MNMD)39 Form 4 lines · source: SEC Form 4

Everything they disclosed

48 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.